CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $118,000 | -38.5% | 17,554 | -61.6% | 0.00% | -40.0% |
| Q2 2022 | $192,000 | +24.7% | 45,688 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $154,000 | +6.9% | 45,688 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $144,000 | -44.8% | 45,688 | -42.8% | 0.00% | -50.0% |
| Q3 2021 | $261,000 | -12.7% | 79,832 | +12.6% | 0.00% | -33.3% |
| Q2 2021 | $299,000 | -25.2% | 70,915 | -11.6% | 0.01% | -25.0% |
| Q1 2021 | $400,000 | +225.2% | 80,192 | +283.7% | 0.01% | +100.0% |
| Q3 2019 | $123,000 | -46.3% | 20,898 | +9.6% | 0.00% | -42.9% |
| Q2 2019 | $229,000 | -48.2% | 19,060 | -1.2% | 0.01% | -50.0% |
| Q1 2018 | $442,000 | +281.0% | 19,290 | +67.6% | 0.01% | +366.7% |
| Q3 2016 | $116,000 | -17.7% | 11,507 | -8.5% | 0.00% | 0.0% |
| Q2 2016 | $141,000 | -22.1% | 12,582 | -5.3% | 0.00% | -40.0% |
| Q1 2016 | $181,000 | -76.6% | 13,282 | -74.0% | 0.01% | -80.0% |
| Q1 2015 | $773,000 | – | 51,025 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |